New metabolic signature for Chagas disease reveals sex steroid perturbation in humans and mice

by Golizeh M, Nam J, Chatelain E, Jackson Y, Ohlund LB, Rasoolizadeh A, Camargo FV, Mahrouche L, Furtos A, Sleno L, Ndao M. Heliyon 2022;8(12)E12380. doi: 10.1016/j.heliyon.2022.e12380

Summary: Current diagnostic tools for Chagas disease are inadequate for chronically infected patients. The authors of this study have previously shown that fragments of apolipoprotein A1 and fibronectin have potential as biomarkers of treatment efficacy. To understand the underlying processes, they conducted untargeted metabolomics analysis on samples from chronic Chagas disease patients, prior to and three years after treatment, and from demographically matched people without Chagas disease. Sex steroids were among the most significantly altered metabolites in Chagas disease patients, a result corroborated by a study in T. cruzi-infected mice. The metabolic alterations identified in this study shed light on the pathogenesis of Chagas disease and provide the basis for developing novel assays for the diagnosis and screening of patients.

The post New metabolic signature for Chagas disease reveals sex steroid perturbation in humans and mice first appeared on DNDi.

Ayuda a los pacientes desatendidos

Hasta la fecha, hemos desarrollado nueve tratamientos para enfermedades desatendidas, salvando millones de vidas. Nuestro objetivo es poner a disposición 25 nuevos tratamientos en nuestros primeros 25 años. ¡Nos puedes ayudar!

Organización internacional sin fines de lucro que desarrolla tratamientos seguros, efectivos y asequibles para los pacientes más desatendidos.

DNDi Global

Contáctenos

DNDi en el mundo

Apoye la DNDi

¡Haga una donación!

Trabaje con nosotros

Oportunidads

A excepción de imágenes, películas y marcas comerciales que están sujetas a los Términos de uso de la DNDi, el contenido de este sitio tiene una licencia Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License.